Related Experiment Videos
[A case of GM-Gangliosidosis (atypical form of the AB variant)]
Insights
This study reports an atypical case of GM-gangliosidosis, variant AB, in a child with progressive neurological decline. Despite normal enzyme levels, investigations revealed visceral involvement and a novel phosphoglycolipid-protein complex, suggesting a unique disease variant.
Area of Science:
- Biochemistry
- Neurology
- Genetics
Background:
- GM-gangliosidosis is a group of rare lysosomal storage diseases characterized by the accumulation of GM2 gangliosides in various tissues.
- Variant AB of GM-gangliosidosis, according to Sandhoff's classification, is typically associated with deficiencies in specific enzymes leading to distinct clinical and pathological features.
- Neurolipidosis encompasses a spectrum of genetic disorders affecting lipid metabolism and storage, often presenting with progressive neurological deterioration.
Observation:
- A male child presented with progressive cerebral disease, motor, and mental impairment starting at 2.5 years of age.
- Peripheral blood leukocyte enzymatic activities were within normal limits, not indicating a typical neurolipidosis deficit.
- Autopsy revealed GM-gangliosidosis with visceral involvement, including the presence of GM2 ganglioside and a novel phosphoglycolipid-protein complex in organ extracts.
Findings:
- The case exhibited atypical features, with clinical signs aligning with O'Brien's type 3 classification and histopathological aspects resembling Tay-Sachs disease (Sandhoff's variant B).
- Enzymatic data suggested a potential variant AB classification, yet clinical and pathological findings deviated from established criteria.
- The identification of an uncharacterized phosphoglycolipid-protein complex in affected organs represents a novel finding in GM-gangliosidosis.
Implications:
- This case highlights the complexity and heterogeneity within GM-gangliosidosis, particularly variant AB, suggesting the existence of atypical presentations.
- The novel compound may play a role in the pathogenesis of this specific variant, necessitating further research for its characterization and functional significance.
- Further studies are crucial for refining the classification and understanding the full spectrum of GM-gangliosidosis, potentially leading to improved diagnostic and therapeutic strategies.
Abstract:
A case of GM-gangliosidosis, variant AB, with some atypical feautres is reported in a male child, who died at the age of 4 years and 3 months. When he was 2 and a half years old, he showed signs of progressive cerebral disease with increasing motor and mental impairment. The clinical signs suggested a form of neurolipidosis; however the data of the enzymatic activities of the peripheral blood leucocytes did not show any deficit related to these forms. More specifically the values of the exosaminides A and B were normal, although the component A was near the lowest limit of the range. The anatomical, histological, histochemical, ultrastructural and chemical studies showed that it was a form of GM-gangliosidosis with visceral involvement. In the crude lipid extracts of various organs there was not only GM-ganglioside, but also a compound not previously demonstrated in these forms of neurolipidosis. Chemically this compound may be considered a phosphoglyco-lipid-and protein complex. From the enzymatic data in the peripheral blood leucocytes, the case may be a variant AB of the Sandhoff and al. classification (1971). However some clinical signs make our case closer to the 3th type of the O'Brien and al, classification while some histopathological aspects are similar to Tay-Sachs disease (i.e. to the variant B of the Sandhoff et al. classification; i.e. to the 1th type of the O'Brien et al. classification). These data, and the presence of an 'unknown compound', not yet demonstrated in the known forms of GM-gangliosidosis, support the hypothesis that our case may be considered as an 'atypical' form of the variant AB of the gangliosidosis GM and that further studies are necessary to reach a final nosography of these entities.